An intelligent screener for mild cognitive impairment via integrated eye-tracking and the digital clock drawing test.

Geriatrics Ophthalmology Hospital-Based Medicine Neurology Nursing
Journal: Journal of Alzheimer's disease : JAD
Published Date:

Abstract

BackgroundMild cognitive impairment (MCI) is a risk factor for dementia, and early screening is crucial for patient prognosis.ObjectiveTo construct an intelligent family screening model for MCI based on eye tracking (ET) and digital clock drawing tests (dCDT), to provide a simple and accurate screening tool for MCI.MethodsThis study included 618 cognitively normal participants and 179 patients with MCI, among whom demographic information and metrics from ET and dCDT were collected. One-way analysis of variance was applied to screen all variables (p < 0.05). Different feature sets constructed based on logistic regression and five machine learning methods (random forests, multilayer perceptron, support vector machines, extreme gradient boosting trees, and convolutional neural networks) were used to construct 36 MCI screening tools. Finally, the diagnostic efficacy of the models was evaluated based on the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, and specificity.ResultsMultimodal features, namely demographics, dCDT, and ET, showed superior performance compared to models based on unimodal behavioral data with or without demographics. Among all algorithms, the random forest model based on all significant features performed the best, with an AUROC of 0.947.ConclusionsHerein, we integrated demographic information, eye tracking, and digital drawing clock tests to construct an MCI screening model that yielded superior classification performance. As a potential intelligent screening tool for MCI in the community, we aim to further build a multicenter external validation study to improve the model's generalizability.

Authors

  • Jinyu Chen
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Chenxi Hao
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Xiaonan Zhang
    Department of Natural Language Processcing, Baidu International Technology (Shenzhen) Co., Ltd, Shenzhen 518000, China.
  • Wencheng Zhu
    Beijing CAS-Ruiyi Information Technology Co., Ltd, Beijing, China.
  • Sijia Hou
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Junpin An
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Wenjing Bao
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhigang Wang
    Institute for Medical Science and Technology, University of Dundee, Dundee DD2 1FD, UK.
  • Shuning Du
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Qiuyan Wang
    Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Guowen Min
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Yarong Zhao
    Department of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
  • Yang Li
    Occupation of Chinese Center for Disease Control and Prevention, Beijing, China.

Keywords

No keywords available for this article.